Long-term survival after central nervous system relapse in a patient with osteosarcoma
β Scribed by Leonard H. Wexler; Thomas F. Delaney; Stephen Saris; Marc E. Horowitz
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 591 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
While the proportion of patients with Ewing's sarcoma attaining and maintaining long-term remission has markedly improved, a proportion of patients suffer relapse of the tumor. In our experience relapses may occur late in the course of the disease, approximately 20% of those at risk beyond 5 years h
Background. A retrospective study of long term outcome after the development of metastases from osteosarcoma was performed, with emphasis on the impact of different treatment strategies and the identification of prognostic factors. Methods. From 1975 to 1993, a population-based series of 60 patient
## Background. Primary central nervous system lymphoma (PCNSL) is the most common brain tumor occurring in patients with acquired immune deficiency syndrome (AIDS). After diagnosis of PCNSL, the median sur- vival time is 2-5 months with treatment with whole brain irradiation (WBI). Methods. Four (
## Abstract The 18qβ syndrome is relatively common among cytogenetic abnormalities occurring in approximately 1 in 40,000 live births. However, interstitial deletions involving 18q12.2 to q21.1 are much less common. Only 15 cases have been reported in the literature. A phenotypic pattern is emergin